Ectopic ACTH Syndrome – Experience with Etomidate / Journal of the ASEAN Federation of Endocrine Societies
Journal of the ASEAN Federation of Endocrine Societies
;
: 54-56, 2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-998460
ABSTRACT
@#For ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS), when surgery is not feasible, or in cases of severe biochemical disturbances, immunosuppression or mental instability, medical therapy with agents such as etomidate is indicated. We present our experience in using etomidate for a 41-year old female with EAS secondary to a malignant mediastinal paraganglioma. We were able to demonstrate that etomidate can be used effectively to control severe hypercortisolism in a lower dose than previously described.
Recherche sur Google
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Syndrome de sécrétion ectopique d'ACTH
/
Syndrome de Cushing
/
Étomidate
langue:
Anglais
Texte intégral:
Journal of the ASEAN Federation of Endocrine Societies
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS